Hong Kong
· Delayed Price · Currency is HKD Genscript Biotech Statistics
Total Valuation
HKG:1548 has a market cap or net worth of HKD 36.95 billion. The enterprise value is 37.77 billion.
| Market Cap | 36.95B |
| Enterprise Value | 37.77B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1548 has 2.18 billion shares outstanding. The number of shares has increased by 3.37% in one year.
| Current Share Class | 2.18B |
| Shares Outstanding | 2.18B |
| Shares Change (YoY) | +3.37% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 14.61% |
| Float | 1.37B |
Valuation Ratios
The trailing PE ratio is 1.61 and the forward PE ratio is 24.69.
| PE Ratio | 1.61 |
| Forward PE | 24.69 |
| PS Ratio | 8.00 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 62.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 105.87, with an EV/FCF ratio of -40.47.
| EV / Earnings | 1.64 |
| EV / Sales | 8.18 |
| EV / EBITDA | 105.87 |
| EV / EBIT | n/a |
| EV / FCF | -40.47 |
Financial Position
The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.72 |
| Quick Ratio | 2.46 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 8.51 |
| Debt / FCF | -6.02 |
| Interest Coverage | 1.16 |
Financial Efficiency
Return on equity (ROE) is -5.46% and return on invested capital (ROIC) is 0.15%.
| Return on Equity (ROE) | -5.46% |
| Return on Assets (ROA) | 0.13% |
| Return on Invested Capital (ROIC) | 0.15% |
| Return on Capital Employed (ROCE) | 0.19% |
| Revenue Per Employee | 829,323 |
| Profits Per Employee | 4.13M |
| Employee Count | 5,568 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 7.64 |
Taxes
In the past 12 months, HKG:1548 has paid 23.12 million in taxes.
| Income Tax | 23.12M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +86.37% in the last 52 weeks. The beta is 0.97, so HKG:1548's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +86.37% |
| 50-Day Moving Average | 11.80 |
| 200-Day Moving Average | 11.57 |
| Relative Strength Index (RSI) | 82.32 |
| Average Volume (20 Days) | 33,265,034 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1548 had revenue of HKD 4.62 billion and earned 23.01 billion in profits. Earnings per share was 10.85.
| Revenue | 4.62B |
| Gross Profit | 2.11B |
| Operating Income | 72.10M |
| Pretax Income | -1.33B |
| Net Income | 23.01B |
| EBITDA | 544.00M |
| EBIT | 72.10M |
| Earnings Per Share (EPS) | 10.85 |
Balance Sheet
The company has 4.83 billion in cash and 5.62 billion in debt, giving a net cash position of -796.15 million or -0.37 per share.
| Cash & Cash Equivalents | 4.83B |
| Total Debt | 5.62B |
| Net Cash | -796.15M |
| Net Cash Per Share | -0.37 |
| Equity (Book Value) | 33.58B |
| Book Value Per Share | 15.66 |
| Working Capital | 4.10B |
Cash Flow
In the last 12 months, operating cash flow was 587.59 million and capital expenditures -1.52 billion, giving a free cash flow of -933.18 million.
| Operating Cash Flow | 587.59M |
| Capital Expenditures | -1.52B |
| Free Cash Flow | -933.18M |
| FCF Per Share | -0.43 |
Margins
Gross margin is 45.77%, with operating and profit margins of 1.56% and 498.22%.
| Gross Margin | 45.77% |
| Operating Margin | 1.56% |
| Pretax Margin | -28.73% |
| Profit Margin | 498.22% |
| EBITDA Margin | 11.78% |
| EBIT Margin | 1.56% |
| FCF Margin | n/a |
Dividends & Yields
HKG:1548 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.37% |
| Shareholder Yield | n/a |
| Earnings Yield | 62.26% |
| FCF Yield | -2.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:1548 has an Altman Z-Score of 2.99 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.99 |
| Piotroski F-Score | 4 |